Cleared Traditional

K904457 - DIAL-AWAY PAIN

K904457 is an FDA 510(k) clearance for DIAL-AWAY PAIN, manufactured by R.F.P., Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 184-day FDA review.

K904457 · R.F.P., Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1991
Decision
184d
Days
Class 2
Risk

K904457 is an FDA 510(k) clearance for the DIAL-AWAY PAIN. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by R.F.P., Inc. (Aurora, US). The FDA issued a Cleared decision on April 3, 1991 after a review of 184 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all R.F.P., Inc. devices

FDA 510(k) Submission Details - K904457

510(k) Number K904457 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 1990
Decision Date April 03, 1991
Days to Decision 184 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d slower than avg
Panel avg: 148d · This submission: 184d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 291
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K904457.
ELECTRO-NEVE STIMULATOR TENS MODEL BIOMED PLUS/A
K905230 · Biomedical Life Systems, Inc. · Jun 1991
ELECTRO-NERVE STIMULATOR TENS MODEL SYSTEMS 2000/A
K905377 · Biomedical Life Systems, Inc. · Jun 1991
ELECTRO-NERVE STIMULATOR TENS MODEL BIOMED 2000/A
K905570 · Biomedical Life Systems, Inc. · Jun 1991
MC II (TM), MODEL 7200S
K903161 · Medical Devices, Inc. · Mar 1991
DYNATRON 200 MICROCURRENT
K903577 · Dynatronics Corp. · Mar 1991
SYNAPS (TM)
K903828 · Henley Intl. · Jan 1991